Activating a β-catenin signal in the liver is oncogenic;Activer un signal β-caténine dans le foie est oncogénique

Medecine/Sciences

Volumn 21, Issue 4, 2005, Pages 355-357

  Colnot, Sabine ^a   Decaens, Thomas ^a   Perret, Christine ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; PROTEIN P53; RECOMBINASE; RETINOBLASTOMA PROTEIN; WNT PROTEIN;

CARCINOGENESIS; COLON POLYPOSIS; GENE EXPRESSION; GENE MUTATION; HUMAN; LIVER; NONHUMAN; NOTE; ONCOGENE C MYC; PHENOTYPE; TUMOR SUPPRESSOR GENE;

EID: 17444365498     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2005214355     Document Type: Note

References (10)

1. Hooper ML. The role of the p53 and Rb-1 genes in cancer, development and apoptosis. J Cell Sci 1994; 18 (suppl): 13-7.
2. Cartier N, Miquerol L, Tulliez M, et al. Diet-dependent carcinogenesis of pancreatic islets and liver in transgenic mice expressing oncogenes under the control of the L-type pyruvate kinase gene promoter. Oncoene 1992; 7: 1413-22.
3. Etiemble J, Degott C, Renard CA, et al. Liver-specific expression and high oncogenic efficiency of a c-myc transgene activated by woodchuck hepatitis virus insertion. Oncogene 1994; 9: 727-37.
4. -/- colon carcinoma. Science 1997; 275: 1784-7.
5. Rubinfeld B, Albert I, Porfiri E, et al. Binding of GSK3β to the APC-β-catenin complex and regulation of complex assembly. Science 1996; 272: 1023-6.
6. De La Coste A, Romagnolo B, Billuart P, et al. Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 1998; 95: 8847-51.
7. Buendia MA. Genetics of hepatocellular carcinoma. Semin Cancer Biol 2000; 10: 185-200.
8. Laurent-Puig P, Legoix P, Bluteau O, et al. Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastraenterology 2001; 120: 1763-73.
9. Cadoret A, Ovejero C, Saadi-Kheddouci S, et al. Hepatomegaly in transgenic mice expressing an oncogenic form of β-catenin. Cancer Res 2001; 61: 3245-9.
10. Colnot S, Decaens T, Niwa-Kawakita M, et al. Liver-targeted disruption of Apc in mice activates β-catenin signaling and leads to hepatocellular carcinomas. Proc Natl Acad Sci USA 2004; 101: 17216-21.